Paeds Vivas · clinical-pharmacology-and-therapeutics
Inhaled therapies and device selection — branching viva
Branching viva on inhaled therapies and device selection in children: choosing the device by the age-based ladder, defending why a spacer is essential for pressurised-inhaler delivery, applying the spacer-versus-nebuliser evidence in acute asthma, and resolving a 'failing' inhaled corticosteroid by correcting the device and technique before escalating the dose.
On this page
Study tools
Target exams
Opening — the eighteen-month-old with no spacer
Examiner: An eighteen-month-old with viral wheeze has been prescribed a salbutamol pressurised inhaler with no spacer. What is the correct device, and why is the spacer essential? [1] [8]
Candidate (model): The correct device for this age is a pressurised metered-dose inhaler seated in a small-volume valved holding chamber with a tightly-fitting face mask. The spacer is essential because a pressurised inhaler fires its aerosol cloud in under a tenth of a second at high velocity — far too fast for an infant to time to a single breath — so without a spacer most of the dose deposits in the oropharynx and almost nothing reaches the lung. The spacer intercepts the fast cloud, slows and suspends it, so the infant can clear it by slow tidal breathing over around six breaths, with the mask sealed firmly to the face. A dry-powder inhaler would not work at this age because the child cannot generate the inspiratory flow. [1] [8]
References4ShowHide
- [1]Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest, 2005.PMID 15654001
- [3]van Aalderen WM, Garcia-Marcos L, Gappa M, et al. How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze. NPJ Primary Care Respiratory Medicine, 2015.PMID 25568979
- [5]Cates CJ, Welsh EJ, Rowe BH Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database of Systematic Reviews, 2013.PMID 24037768
- [8]Amirav I, Newhouse MT Aerosol therapy in infants and toddlers: past, present and future. Expert Review of Respiratory Medicine, 2008.PMID 20477295